Creso Pharma
(ASX) CPH
Creso Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$4.67M
Net Income (TTM)
$25.73M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CPH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Creso Pharma
Industry
Pharmaceuticals
Sector
Health CareCEO
William Lay
Website
www.cresopharma.comHeadquarters
Nedlands, WA 6009, AU
CPH Financials
Key Financial Metrics (TTM)
Gross Margin
3%
Operating Margin
-2%
Net Income Margin
-4%
Return on Equity
-1%
Return on Capital
-88%
Return on Assets
-86%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$287.00K
Operating Income
$19.57M
EBITDA
$30.14M
Operating Cash Flow
$30.83M
Capital Expenditure
$348.00K
Free Cash Flow
$31.18M
Cash & ST Invst.
$1.39M
Total Debt
$6.67M
Creso Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.81M
+1198.9%
Gross Profit
$1.06M
+1975.9%
Gross Margin
58.62%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$8.34M
-93.0%
EBITDA
$3.38M
+16.9%
Quarterly Fundamentals
Net Cash
$5.28M
-246.2%
Accounts Receivable
$2.56M
+169.5%
Inventory
$5.77M
+1201.6%
Long Term Debt
$0.00
N/A
Short Term Debt
$6.67M
+140.3%
Return on Assets
-86.31%
N/A
Return on Invested Capital
-87.77%
N/A
Free Cash Flow
$11.84M
-543.4%
Operating Cash Flow
$10.17M
N/A